- Pamabrom
-
-
2026-08-04
- CAS:606-04-2
- Min. Order: 1KG
- Purity: USP, BP
- Supply Ability: 5,000KG
- Pamabrom
-
-
2026-06-30
- CAS:606-04-2
- Min. Order: 1kg
- Purity: 98%
- Supply Ability: 1000kg
- Pamabrom
-
- $46.00
-
2026-05-25
- CAS:606-04-2
- Purity: 99.83%
- Supply Ability: 10g
|
| | Pamabrom Basic information |
| Product Name: | Pamabrom | | Synonyms: | PAMABROM;8-BROMOTHEOPHYLLINE COMPOUND WITH 2-AMINO-2-METHYL-1-PROPANOL (1:1);2-amino-2-methylpropan-1-ol,8-bromo-1,3-dimethyl-7H-purine-2,6-dione;8-bromo-1-methyl-2,6-dioxo-7H-purine-3-carboxylic acid (2-amino-2-methylpropyl) ester;Pamabrom/2-amino-2-methylpropanol
8-bromotheophyllinate;2-amino-2-methylpropanol 8-bromotheophyllinate;PAMABROM,USP;2-azanyl-2-methyl-propan-1-ol | | CAS: | 606-04-2 | | MF: | C11H18BrN5O3 | | MW: | 348.2 | | EINECS: | 210-103-4 | | Product Categories: | API's;Bases & Related Reagents;Intermediates & Fine Chemicals;Nucleotides;Pharmaceuticals | | Mol File: | 606-04-2.mol |  |
| | Pamabrom Chemical Properties |
| Melting point | >300°C | | storage temp. | Refrigerator | | solubility | Methanol, Water | | form | Solid | | color | White | | Merck | 14,7000 | | InChI | InChI=1S/C7H7BrN4O2.C4H11NO/c1-11-4-3(9-6(8)10-4)5(13)12(2)7(11)14;1-4(2,5)3-6/h1-2H3,(H,9,10);6H,3,5H2,1-2H3 | | InChIKey | ATOTUUBRFJHZQG-UHFFFAOYSA-N | | SMILES | C12NC(Br)=NC=1N(C)C(=O)N(C)C2=O.C(N)(C)(C)CO | | CAS DataBase Reference | 606-04-2(CAS DataBase Reference) |
| Hazard Codes | Xn | | Risk Statements | 22 | | WGK Germany | 3 | | HS Code | 2933.59.5900 |
| | Pamabrom Usage And Synthesis |
| Chemical Properties | Pamabrom is White Solid | | Uses | Pamabrom analgesics for urinary tract pain and urgency | | Uses | Pamabrom is a diuretic used to reduce menstrual pains. | | in vivo | Pamabrom (200-800 μg/paw; topical administration) produces a dose-dependent analgesic effect in rats, and its analgesic effect can be blocked by Naloxone (HY-17417A) (50 μg/paw), l-nitro-arginine methyl ester (10-100 μg/paw), 1H-(1,2,4)-oxadiazolo[4,2-a]quinoxalin-1-one (10-100 μg/paw) and K+ channel blockers[1].
|
| | Pamabrom Preparation Products And Raw materials |
|